FREE Account Opening + No Clearing Fees
Loading...

IKIO Lighting IPO vs Mankind Pharma IPO

Comparision between IKIO Lighting IPO and Mankind Pharma IPO.

IPO Details

IKIO Lighting IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Mankind Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of IKIO Lighting IPO is up to ₹606.50 Cr whereas the issue size of the Mankind Pharma IPO is up to ₹4,326.36 Cr. The final issue price of IKIO Lighting IPO is ₹285.00 per share and of Mankind Pharma IPO is ₹1,080.00 per share.

  IKIO Lighting IPO Mankind Pharma IPO
Face Value ₹10 per share ₹1 per share
Issue Price (Lower) ₹270.00 per share ₹1,026.00 per share
Issue Price (Upper) ₹285.00 per share ₹1,080.00 per share
Issue Price (Final) ₹285.00 per share ₹1,080.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 52 shares 13 shares
Fresh Issue Size 1,22,80,701 shares
Fresh Issue Size (Amount) up to ₹350.00 Cr
OFS Issue Size 90,00,000 shares 4,00,58,844 shares
OFS Issue Size (Amount) up to ₹256.50 Cr up to ₹4,326.36 Cr
Issue Size Total 2,12,80,701 shares 4,00,58,844 shares
Issue Size Total (Amount) up to ₹606.50 Cr up to ₹4,326.36 Cr

IPO Timetable

IKIO Lighting IPO opens on Jun 06, 2023, while Mankind Pharma IPO opens on Apr 25, 2023. The closing date of IKIO Lighting IPO and Mankind Pharma IPO is Jun 08, 2023, and Apr 27, 2023, respectively.

  IKIO Lighting IPO Mankind Pharma IPO
Anchor Bid Date Jun 05, 2023 Apr 24, 2023
Issue Open Jun 06, 2023 Apr 25, 2023
Issue Close Jun 08, 2023 Apr 27, 2023
Basis Of Allotment (Tentative) Jun 13, 2023 May 03, 2023
Initiation of Refunds (Tentative) Jun 14, 2023 May 04, 2023
Credit of Share (Tentative) Jun 15, 2023 May 05, 2023
Listing date (Tentative) Jun 16, 2023 May 09, 2023
Anchor Lockin End date 1 Jul 13, 2023 Jun 02, 2023
Anchor Lockin End date 2 Sep 11, 2023 Aug 01, 2023

Financials

IKIO Lighting IPO P/E ratio is 32.13, as compared to Mankind Pharma IPO P/E ratio of 32.5.

  IKIO Lighting IPO Mankind Pharma IPO
Financial
IKIO Lighting Limited Financial Information (Proforma Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthTotal Borrowing
31-Mar-20144.83221.8321.4135.9046.86
31-Mar-21174.45214.5728.8162.8669.36
31-Mar-22264.87334.0050.52108.87106.56
31-Dec-22335.50332.7951.35140.83136.33
Amount in ₹ Crore
Mankind Pharma Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-205,073.295,975.651,056.153,485.313,436.34126.92
31-Mar-216,372.636,385.381,293.034,722.004,674.39234.53
31-Dec-218,043.886,218.291,260.245,965.465,916.86268.70
31-Mar-229,147.747,977.581,452.966,155.236,106.06868.03
31-Dec-229,273.756,777.821,015.987,145.897,094.12167.93
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 100.00% 79.00%
Promoter Shareholding (Post-Issue) 72.46% 76.50%
P/E Ratio 32.13 32.5
Market Cap ₹2202.50 Cr. ₹43263.60 Cr.
ROE 36.00%% 27.60%%
ROCE 26.00%% 26.10%%
Debt/Equity 1.03
EPS ₹7.90 ₹33.20
RoNW 36.46%% 27.70%%

Shares Offered

In the IKIO Lighting IPO retail investors (RII) are offered 74,48,246 shares while in Mankind Pharma IPO retail investors are offered 74,48,246 shares. Qualified institutional buyers (QIB) are offered 42,56,140 shares in IKIO Lighting IPO and 80,11,769 shares in Mankind Pharma IPO.

  IKIO Lighting IPO Mankind Pharma IPO
Anchor Investor Reserveration 63,84,209 shares 1,20,17,652 shares
Market Maker Reserveration
QIB 42,56,140 shares 80,11,769 shares
NII 31,92,107 shares 60,08,827 shares
RII 74,48,246 shares 1,40,20,596 shares
Employee 0 shares 0 shares
Others
Total 1,48,96,493 shares 2,80,41,192 shares

Bids Received (Subscription)

IKIO Lighting IPO subscribed 67.75x in total, whereas Mankind Pharma IPO subscribed 15.32x.

  IKIO Lighting IPO Mankind Pharma IPO
QIB (times) 163.06x 49.16x
NII (times) 65.38x 3.80x
Big NII (times) 69.01x 4.99x
Small NII (times) 58.13x 1.41x
RII (times) 14.31x 0.92x
Employee (times)
Other (times)
Total (times) 67.75x 15.32x

Comments

Add a public comment...